A systematic review and meta-analysis of the clinical benefits and adverse reactions of anti-fibrotics in non-IPF progressive fibrosing ILD.
Woon Hean ChongDipika AgrawalZe Ying TanSridhar VenkateswaranAdeline Yit Ying TanChing Yee TanNorris Chun Ang LingNoel Stanley Wey Tut TayPublished in: Heart & lung : the journal of critical care (2024)
The advent of anti-fibrotics offers alternative treatment to reduce lung function decline.